logo BDSP

Base documentaire


  1. Barriers to use of free antiretroviral therapy in injection drug users.

    Article - En anglais

    Context. - In British Columbia, human immunodeficiency virus (HIV) - infected persons eligible for antiretroviral therapy may receive it free but the extent to which HIV-infected injection drug users access it is unknown.

    Objective

    - To identify patient and physician characteristics associated with antiretroviral therapy utilization in HIV-infected injection drug users.

    Design

    - Prospective cohort study with record linkage between survey data and data from a provincial HIV/AIDS (acquired immunodeficiency syndrome) drug treatment program.

    Setting

    - British Columbia, where antiretroviral therapies are offered free to all persons with HIV infection with CD4 cell counts less than 0.50x109/L (500/muL) and/or HIV-1 RNA levels higher than 5000 copies/mL.

    Subjects

    - A total of 177 HIV-infected injection drug users eligible for antiretroviral therapy, recruited through the prospective cohort study since May 1996.

    Main Outcome Measures

    - Patient use of antiretroviral drugs through the provincial drug treatment program and physician experience treating HIV infection.

    Results

    - After a median of 11 months after first eligibility, only 71 (40%) of 177 patients had received any antiretroviral drugs, primarily double combinations (47/71 [66% ]). Both patient and physician characteristics were associated with use of antiretroviral drugs. (...)

    Mots-clés Pascal : Toxicomanie, Voie intraveineuse, SIDA, Virose, Infection, Retroviridae, Virus, Comportement, Malade, Pratique professionnelle, Médecin, Chimiothérapie, Traitement, Utilisation, Homme, Colombie britannique, Canada, Amérique du Nord, Amérique, Immunopathologie, Immunodéficit, Personnel sanitaire

    Mots-clés Pascal anglais : Drug addiction, Intravenous administration, AIDS, Viral disease, Infection, Retroviridae, Virus, Behavior, Patient, Professional practice, Physician, Chemotherapy, Treatment, Use, Human, British Columbia, Canada, North America, America, Immunopathology, Immune deficiency, Health staff

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0395193

    Code Inist : 002B06D01. Création : 25/01/1999.